Forskning
Udskriv Udskriv
Switch language
Bispebjerg Hospital - en del af Københavns Universitetshospital
Udgivet

Identifying dominant-negative actions of a dopamine transporter variant in patients with parkinsonism and neuropsychiatric disease

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Cerebrospinal fluid and plasma distribution of anti-α-synuclein IgMs and IgGs in multiple system atrophy and Parkinson's disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Postprandial Increase in Mesenteric Blood Flow is Attenuated in Parkinson's Disease: A Dynamic PC-MRI Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Paroxysmal Cranial Dyskinesia and Nail-Patella Syndrome Caused by a Novel Variant in the LMX1B Gene

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Deep Brain Stimulation in Parkinson's Disease: Still Effective After More Than 8 Years

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Epigenetic modulation of AREL1 and increased HLA expression in brains of multiple system atrophy patients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Freja Herborg
  • Kathrine L Jensen
  • Sasha Tolstoy
  • Natascha V Arends
  • Leonie P Posselt
  • Aparna Shekar
  • Jenny I Aguilar
  • Viktor K Lund
  • Kevin Erreger
  • Mattias Rickhag
  • Matthew D Lycas
  • Markus N Lonsdale
  • Troels Rahbek-Clemmensen
  • Andreas T Sørensen
  • Amy H Newman
  • Annemette Løkkegaard
  • Ole Kjaerulff
  • Thomas Werge
  • Lisbeth B Møller
  • Heinrich Jg Matthies
  • Aurelio Galli
  • Lena E Hjermind
  • Ulrik Gether
Vis graf over relationer

Dysfunctional dopaminergic neurotransmission is central to movement disorders and mental diseases. The dopamine transporter (DAT) regulates extracellular dopamine levels, but the genetic and mechanistic link between DAT function and dopamine-related pathologies is not clear. Particularly, the pathophysiological significance of monoallelic missense mutations in DAT is unknown. Here, we use clinical information, neuroimaging, and large-scale exome-sequencing data to uncover the occurrence and phenotypic spectrum of a DAT coding variant, DAT-K619N, which localizes to the critical C-terminal PSD-95/Discs-large/ZO-1 homology-binding motif of human DAT (hDAT). We identified the rare but recurrent hDAT-K619N variant in exome-sequenced samples of patients with neuropsychiatric diseases and a patient with early-onset neurodegenerative parkinsonism and comorbid neuropsychiatric disease. In cell cultures, hDAT-K619N displayed reduced uptake capacity, decreased surface expression, and accelerated turnover. Unilateral expression in mouse nigrostriatal neurons revealed differential effects of hDAT-K619N and hDAT-WT on dopamine-directed behaviors, and hDAT-K619N expression in Drosophila led to impairments in dopamine transmission with accompanying hyperlocomotion and age-dependent disturbances of the negative geotactic response. Moreover, cellular studies and viral expression of hDAT-K619N in mice demonstrated a dominant-negative effect of the hDAT-K619N mutant. Summarized, our results suggest that hDAT-K619N can effectuate dopamine dysfunction of pathological relevance in a dominant-negative manner.

OriginalsprogEngelsk
Artikelnummere151496
TidsskriftJCI Insight
Vol/bind6
Udgave nummer18
ISSN2379-3708
DOI
StatusUdgivet - 22 sep. 2021

ID: 67621523